Comunicación corta
Ranibizumab intravítreo en neovascularización coroidea secundaria a distrofia foveomacular viteliforme del adulto
Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy
E. Prieto-Calvo
, C. Torrón-Fernández Blanco, C. Egea-Estopiñán, N. Güerri-Monclús, E. Ferrer-Novella, O. Ruiz-Moreno, L.E. Pablo-Julvez
Autor para correspondencia
Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
Leído
4483
Vecesse ha leído el artículo
932
Total PDF
3551
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 1 | 1 |
| 2025 11 | 0 | 15 | 15 |
| 2025 10 | 0 | 9 | 9 |
| 2025 9 | 0 | 6 | 6 |
| 2025 8 | 0 | 13 | 13 |
| 2025 7 | 0 | 11 | 11 |
| 2025 6 | 0 | 8 | 8 |
| 2025 5 | 0 | 7 | 7 |
| 2025 4 | 0 | 5 | 5 |
| 2025 3 | 0 | 10 | 10 |
| 2025 2 | 0 | 18 | 18 |
| 2025 1 | 0 | 9 | 9 |
| 2024 12 | 0 | 4 | 4 |
| 2024 11 | 0 | 10 | 10 |
| 2024 10 | 0 | 6 | 6 |
| 2024 9 | 0 | 5 | 5 |
| 2024 8 | 0 | 8 | 8 |
| 2024 7 | 0 | 4 | 4 |
| 2024 6 | 0 | 5 | 5 |
| 2024 5 | 0 | 7 | 7 |
| 2024 4 | 0 | 30 | 30 |
| 2024 3 | 0 | 23 | 23 |
| 2024 2 | 0 | 11 | 11 |
| 2024 1 | 0 | 3 | 3 |
| 2023 12 | 0 | 12 | 12 |
| 2023 11 | 0 | 30 | 30 |
| 2023 10 | 0 | 7 | 7 |
| 2023 9 | 0 | 11 | 11 |
| 2023 7 | 0 | 9 | 9 |
| 2023 6 | 0 | 4 | 4 |
| 2023 5 | 0 | 1 | 1 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 0 | 3 | 3 |
| 2023 2 | 0 | 4 | 4 |
| 2022 1 | 0 | 10 | 10 |
| 2022 12 | 0 | 1 | 1 |
| 2022 11 | 1 | 6 | 7 |
| 2022 10 | 0 | 5 | 5 |
| 2022 9 | 0 | 7 | 7 |
| 2022 8 | 0 | 6 | 6 |
| 2022 6 | 0 | 1 | 1 |
| 2022 5 | 0 | 6 | 6 |
| 2022 4 | 0 | 3 | 3 |
| 2021 1 | 0 | 2 | 2 |
| 2021 12 | 0 | 5 | 5 |
| 2021 11 | 0 | 3 | 3 |
| 2021 10 | 0 | 5 | 5 |
| 2021 7 | 0 | 2 | 2 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 0 | 6 | 6 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 0 | 1 | 1 |
| 2021 2 | 0 | 7 | 7 |
| 2020 1 | 0 | 4 | 4 |
| 2020 12 | 1 | 5 | 6 |
| 2020 11 | 0 | 4 | 4 |
| 2020 10 | 0 | 9 | 9 |
| 2020 9 | 0 | 3 | 3 |
| 2020 8 | 0 | 13 | 13 |
| 2020 7 | 0 | 2 | 2 |
| 2020 6 | 1 | 9 | 10 |
| 2020 5 | 1 | 6 | 7 |
| 2020 4 | 0 | 3 | 3 |
| 2020 2 | 0 | 5 | 5 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 18 | 18 |
| 2019 10 | 6 | 1 | 7 |
| 2019 9 | 0 | 6 | 6 |
| 2019 8 | 0 | 6 | 6 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 0 | 2 | 2 |
| 2019 5 | 0 | 49 | 49 |
| 2019 4 | 0 | 5 | 5 |
| 2019 2 | 1 | 3 | 4 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 0 | 4 | 4 |
| 2018 10 | 0 | 4 | 4 |
| 2018 3 | 11 | 0 | 11 |
| 2018 2 | 19 | 1 | 20 |
| 2018 1 | 41 | 1 | 42 |
| 2017 12 | 43 | 1 | 44 |
| 2017 11 | 18 | 3 | 21 |
| 2017 10 | 31 | 3 | 34 |
| 2017 9 | 30 | 5 | 35 |
| 2017 8 | 23 | 1 | 24 |
| 2017 7 | 31 | 4 | 35 |
| 2017 6 | 27 | 31 | 58 |
| 2017 5 | 44 | 4 | 48 |
| 2017 4 | 30 | 2 | 32 |
| 2017 3 | 39 | 49 | 88 |
| 2017 2 | 40 | 0 | 40 |
| 2016 1 | 41 | 2 | 43 |
| 2016 12 | 59 | 8 | 67 |
| 2016 11 | 73 | 4 | 77 |
| 2016 10 | 73 | 8 | 81 |
| 2016 9 | 89 | 4 | 93 |
| 2016 8 | 49 | 2 | 51 |
| 2016 7 | 53 | 1 | 54 |
| 2016 6 | 55 | 9 | 64 |
| 2016 5 | 63 | 9 | 72 |
| 2016 4 | 44 | 6 | 50 |
| 2016 3 | 57 | 4 | 61 |
| 2016 2 | 48 | 9 | 57 |
| 2015 1 | 49 | 11 | 60 |
| 2015 12 | 58 | 12 | 70 |
| 2015 11 | 45 | 12 | 57 |
| 2015 10 | 66 | 11 | 77 |
| 2015 9 | 59 | 9 | 68 |
| 2015 8 | 57 | 7 | 64 |
| 2015 7 | 99 | 8 | 107 |
| 2015 6 | 46 | 4 | 50 |
| 2015 5 | 86 | 12 | 98 |
| 2015 4 | 61 | 8 | 69 |
| 2015 3 | 106 | 10 | 116 |
| 2015 2 | 100 | 5 | 105 |
| 2015 1 | 60 | 9 | 69 |
| 2014 12 | 60 | 5 | 65 |
| 2014 11 | 60 | 11 | 71 |
| 2014 10 | 72 | 4 | 76 |
| 2014 9 | 55 | 5 | 60 |
| 2014 8 | 34 | 4 | 38 |
| 2014 7 | 50 | 5 | 55 |
| 2014 6 | 59 | 5 | 64 |
| 2014 5 | 36 | 5 | 41 |
| 2014 4 | 23 | 1 | 24 |
| 2014 3 | 31 | 4 | 35 |
| 2014 2 | 30 | 4 | 34 |
| 2014 1 | 29 | 1 | 30 |
| 2013 12 | 25 | 4 | 29 |
| 2013 11 | 31 | 3 | 34 |
| 2013 10 | 40 | 6 | 46 |
| 2013 9 | 36 | 5 | 41 |
| 2013 8 | 29 | 8 | 37 |
| 2013 7 | 13 | 1 | 14 |
| 2012 4 | 803 | 0 | 803 |
Mostrar todo
